Navigation Links
Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
Date:4/29/2008

PITTSBURGH, April 29 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Michael J. Monroe as senior vice president - Global Public Affairs and as a member of the company's senior leadership team. In this role, Monroe is responsible globally for executive, financial and employee communications; corporate branding/marketing; corporate media relations; Internet management, sponsorships and event planning. In addition, he oversees the strategic coordination of communications for the company, working closely with Mylan's operating and support units.

"Mike is a talented and experienced senior executive," said Mylan's Vice Chairman and CEO Robert J. Coury. "His broad-based background and understanding of international public affairs will serve Mylan well as we strengthen our strategic global communications activities. We are fortunate to have added someone of Mike's caliber to Mylan's senior leadership team."

Monroe served previously as executive vice president - Public Affairs and chief communications officer for KeyCorp, one of the nation's largest financial services companies. During his 30 year career, he also completed assignments of increasing responsibility at CIGNA Corporation, The American Express Company and AT&T Long Lines Division.

Monroe earned a bachelor's degree from Rutgers University, graduating magna cum laude. He also holds a master's degree in journalism from Columbia University.

He is a member of The Phi Beta Kappa Society, The Public Relations Seminar and The Wisemen. He has chaired the Public Affairs Council of The Financial Services Roundtable and is the former chair of The Conference Board's Communications Council.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Announces Final FDA Approval for Trandolapril Tablets
2. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
3. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
4. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
5. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
6. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
7. Mylan Restores Availability of Generic Levothyroxine in Florida
8. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
9. Mylan Declares Quarterly Preferred Stock Dividend
10. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
11. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... My T Chai, a South African company that creates a number of ... a popular website specializing in sales of nutritional products. , Chai tea is ... It spread across Asia and Africa quickly, and today recipes vary from region to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As ... use of this type of healthcare model in the diagnosis and treatment of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... As a former ... a thousand words. The good news for single women is that she put all ... is available on April 25th. Joan's insight, personal experiences and sparkling sense of humor ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study of ... student well-being has seriously declined. "When disenfranchised youth from the heart of our ... State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle East ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
(Date:4/19/2017)... -- Companion animal vaccines are ... such as canine, avian and feline. ... as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, ... Vaccines. Attenuated live vaccines are derived from disease-causing ... been weakend under laboratory conditions. Conjugate vaccines are ...
Breaking Medicine Technology: